Award recordCONTRACT

GENZYME CORPORATION

PIID VA24817F1608· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $75,583 net obligations· UEI X2XMAQLR9DA8· MA

Description

LEMTRADA INJECTION VIALS

First action · last action
2017-04-14 · 2017-04-14
Transactions
1
First transaction's obligation
$75,583
Base + all options value (sum of deltas)
$75,583
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2086D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$75,583$0Base award · 2017-04-14 · this action $75,583 · running total $75,583
  • Base2017-04-14+$75,583= $75,583
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-04-14+$75,583$75,583LEMTRADA INJECTION VIALS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI X2XMAQLR9DA8)

AwardOffice · PSC / listingNet obligationsFY
36E79724A0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26124N0260261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$11,882FY2024
36C26023F0186260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$144,553FY2023
36C26223F0045262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$246,001FY2023
36C26223F0022262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$266,652FY2023
36C26222F0606262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$20,049FY2022

Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826F0207CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8 (36C248)$183,903FY2026
36C24826P1108ASD SPECIALTY HEALTHCARE, LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$54,600FY2026
36C24826P1090SIRTEX MEDICAL INC248-NETWORK CONTRACT OFFICE 8 (36C248)$45,825FY2026
36C24826N0511BIOMERIEUX INC248-NETWORK CONTRACT OFFICE 8 (36C248)$61,788FY2026
36C24826N0693MEDI-PHYSICS, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$111,150FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24817F1608_3600_V797P2086D_3600 · retrieved 2026-09-26.